PRF Technologies Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.360
-0.120 (-8.11%)
At close: Jun 12, 2026, 4:00 PM EDT
1.340
-0.020 (-1.49%)
After-hours: Jun 12, 2026, 7:48 PM EDT
PRF Technologies Employees
As of December 31, 2025, PRF Technologies had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
$2,429
Profits / Employee
-$691,143
Market Cap
1.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 1 | 16.67% | 6 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 2 | 4 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 2 | 50.00% | 6 | 0 |
| Dec 31, 2021 | 4 | 2 | 100.00% | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| Sunshine Biopharma | 50 |
| IM Cannabis | 44 |
| cbdMD | 42 |
| RedHill Biopharma | 13 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 8 |
| Gelteq | 8 |
PRFX News
- 14 days ago - Why Is Penny Stock PRF Technologies (PRFX) Up Today? - TipRanks
- 15 days ago - PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets - GlobeNewsWire
- 17 days ago - PRF Technologies announces results from study comparing PRF-110 to Zynrelef - TheFly
- 17 days ago - PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study - GlobeNewsWire
- 4 weeks ago - PRF Technologies registers to sell 3M ordinary shares for holders - TheFly
- 6 weeks ago - PRF Technologies announces FDA clearance of OcuRing-K NDA - TheFly
- 6 weeks ago - PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial - GlobeNewsWire
- 2 months ago - PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms - GlobeNewsWire